Top compounds associated with response to ARSH


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.3
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.031 0.3
mRNA Tamoxifen GDSC1000 pan-cancer AAC -0.032 0.3
mRNA spautin-1 CTRPv2 pan-cancer AAC -0.036 0.3
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.036 0.3
mRNA DBeQ CTRPv2 pan-cancer AAC -0.035 0.3
mRNA EHT 1864 GDSC1000 pan-cancer AAC -0.032 0.3
mRNA simvastatin CTRPv2 pan-cancer AAC -0.037 0.3
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.033 0.3
Download CSV